Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 20 /hr

★★★★★

☆☆☆☆☆

Hire Dr. Thanakorn P.

Thailand

USD 20 /hr

Scientific Writer & Scientist/Researcher with 10+ years of experience in molecular medicine

Profile Summary

I am a postgraduate in doctoral degree of molecular biomedicine from Friedrich-Schiller Universität Jena (Germany) and a former Scientific and Manufacturing Director at StemCells21’s Bio-Pharma Laboratories (Thailand). With my intense academic background and research experiences in biomedical laboratories, I am highly skilled in molecular biomedical laboratory techniques. Importantly, with my critical thinking, I have experiences with writing, preparing, publishing, and reviewing publications for many publishers. In line with this, I have in total so far 15 publications recognized by PubMed NCBI with 5 first author publications. Managing skills are also my talent. My roles as scientific and manufacturing director were to direct and oversee the overall ongoing/working performance of all departments of the bio-pharma laboratories facility (for modern drug production like ATMPs, biological drugs, cell therapy products, etc.) of the company including production, QC, QA, Admin, and R&D.

Subject Matter Expertise

• ★ Molecular Biology
• ★ Cancer Biology
• ★ Manuscript & Journal Article Writing
• ☆ Biomarkers
• ☆ Genetics
• ☆ PCR
• ☆ Molecular Cloning
• ☆ Next Generation Sequencing (NGS)
• ☆ DNA Sequencing
• ☆ Gene Expression Analysis
• ☆ Genome Sequencing
• ☆ Exome Sequencing
• ☆ Cell Biology
• ☆ Cell-Based Assays
• ☆ Cell Signaling Pathways
• ☆ Gene Regulation
• ☆ Stem Cell Research
• ☆ Cell Culture
• ☆ Primary Cells
• ☆ Cell Banking
• ☆ Cell Line Engineering
• ☆ Large Scale Cell Culture
• ☆ Cell Surface Receptors
• ☆ 3D Cell Culture
• ☆ Cell Aging
• ☆ Critical Theory
• ☆ Preclinical Research
• ☆ In vitro Preclinical Toxciology
• ☆ Medical Genetics
• ☆ Prostate Cancer
• ☆ Molecular Pathology
• ☆ Medical Education
• ☆ Immunotherapy
• ☆ Medical Sciences
• ☆ Cancer Research
• ☆ Concept Development
• ☆ Hypothesis
• ☆ Peer Review
• ☆ Research Methodology
• ☆ Literature Search
• ☆ Instructional Webinars
• ☆ Skills Training
• ☆ Medical Writing
• ☆ Healthcare Communications
• ☆ Research Summaries & Abstracts
• ☆ Technical & Scientific Writing
• ☆ Experimental Protocols
• ☆ SOP & Protocol Writing
• ☆ Textbook Content Writing
• ☆ Science Communication
• ☆ Literature Review
• ☆ Traditional/Narrative Literature Review
• ☆ Scientific Proofreading & Editing
• ☆ Proofreading & Editing
• ☆ Language Translation
• ☆ Creative Writing

Services

• Writing
• Research
• Consulting

Writing Medical Writing, Technical Writing, Creative Writing, General Proofreading & Editing, Translation

Research User Research, Technology Scouting, Scientific and Technical Research, Systematic Literature Review

Consulting Operations Consulting, Scientific and Technical Consulting, Manufacturing Consulting

Work Experience

Scientific and Manufacturing Director

StemCells21’s Bio-Pharma Laboratories

April 2022 - May 2024

Education

Dr. rer. nat. (Institute of Human Genetics)

Friedrich-Schiller-Universität Jena

October 2016 - July 2021

Certifications

• Certification details not provided.

Publications

JOURNAL ARTICLE

Atri Roozbahani G, Kokal-Ribaudo M, Heidari Horestani M, Pungsrinont T, Baniahmad A (2024). The protein composition of exosomes released by prostate cancer cells is distinctly regulated by androgen receptor-antagonists and -agonist to stimulate growth of target cells . Cell communication and signaling : CCS.

Pungsrinont T, Schneider MA, Baniahmad A (2023). Androgen receptor agonist and antagonist reduce response of cytokine-induced killer cells on prostate cancer cells . Journal of cellular and molecular medicine.

Ehsani M, Bartsch S, Rasa SMM, Dittmann J, Pungsrinont T, Neubert L, Huettner SS, Kotolloshi R, Schindler K, Ahmad A, et al. (2022). The natural compound atraric acid suppresses androgen-regulated neo-angiogenesis of castration-resistant prostate cancer through angiopoietin 2 . Oncogene.

Pungsrinont T, Kallenbach J, Baniahmad A (2021). Role of PI3K-AKT-mTOR Pathway as a Pro-Survival Signaling and Resistance-Mediating Mechanism to Therapy of Prostate Cancer . International journal of molecular sciences.

Bartsch S, Mirzakhani K, Neubert L, Stenzel A, Ehsani M, Esmaeili M, Pungsrinont T, Kacal M, Rasa SMM, Kallenbach J, et al. (2021). Antithetic hTERT Regulation by Androgens in Prostate Cancer Cells: hTERT Inhibition Is Mediated by the ING1 and ING2 Tumor Suppressors . Cancers.

Melekhova A, Leeder M, Pungsrinont T, Schmäche T, Kallenbach J, Ehsani M, Mirzakhani K, Rasa SMM, Neri F, Baniahmad A (2021). A Novel Splice Variant of the Inhibitor of Growth 3 Lacks the Plant Homeodomain and Regulates Epithelial-Mesenchymal Transition in Prostate Cancer Cells . Biomolecules.

(2021). Association between intelectin-1 variation and human kidney stone disease in northeastern Thai population . Urolithiasis.

(2021). Mouse models for hereditary spastic paraplegia uncover a role of PI4K2A in autophagic lysosome reformation . Autophagy.

(2020). Mechanisms of Androgen Receptor Agonist- and Antagonist-Mediated Cellular Senescence in Prostate Cancer . Cancers.

(2020). Interleukin-23 Represses the Level of Cell Senescence Induced by the Androgen Receptor Antagonists Enzalutamide and Darolutamide in Castration-Resistant Prostate Cancer Cells . Hormones & cancer.

(2020). Thyroid hormone induces cellular senescence in prostate cancer cells through induction of DEC1 . The Journal of steroid biochemistry and molecular biology.

(2020). Senolytic compounds control a distinct fate of androgen receptor agonist- and antagonist-induced cellular senescent LNCaP prostate cancer cells . Cell & bioscience.

(2018). A reciprocal feedback between the PDZ binding kinase and androgen receptor drives prostate cancer . Oncogene.

(2016). The activation of OR51E1 causes growth suppression of human prostate cancer cells . Oncotarget.

(2016). A novel crosstalk between the tumor suppressors ING1 and ING2 regulates androgen receptor signaling . Journal of molecular medicine (Berlin, Germany).